Hybrid Fusion Medicals - HFM AG
About Hybrid Fusion Medicals - HFM AG
Categories
![Hybrid Fusion Medicals - HFM AG](https://www.cphi-online.com/Picture1-comp308136.png)
-
CH
-
2022On CPHI since
-
1 - 24Employees
Company types
Primary activities
Hybrid Fusion Medicals - HFM AG Resources (1)
-
Brochure Elevator Pitch
HFM is a Californian-Swiss Biotech company developing new drugs in virology, immunology and oncology with a focus on COVID-19 since December 2019.
Acute and even more Chronic Covid continue to remain major challenges. There are a few drugs on the market which are however not being used widely due to lack of efficacy and difficult challenges in prescriptions. Also vaccines are not the solution for various reasons.
We have developed two drugs against acute and chronic Covid- 19, preventive as well as for treatment, ready for market entry in Q4 -2022.
Position your company at the heart of the global Pharma industry with a CPHI Online membership
-
Your products and solutions visible to thousands of visitors within the largest Pharma marketplace
-
Generate high-quality, engaged leads for your business, all year round
-
Promote your business as the industry’s thought-leader by hosting your reports, brochures and videos within your profile
-
Your company’s profile boosted at all participating CPHI events
-
An easy-to-use platform with a detailed dashboard showing your leads and performance